Lipella Pharmaceuticals to Present at 2024 Spartan Capital Investor Conference

Rhea-AI Summary

Lipella Pharmaceuticals (Nasdaq: LIPO), a clinical-stage biotechnology company, has announced its participation in the 2024 Spartan Capital Investor Conference. CEO Jonathan Kaufman, PhD, will deliver a presentation on November 4th, 2024, at 9:25 am EST at the Pierre Hotel in New York. The company, which focuses on addressing serious diseases with significant unmet needs, will also offer one-on-one meetings with registered conference investors.

News Market Reaction – LIPO

-1.24%

1 alert

-1.24% News Effect

On the day this news was published, LIPO declined 1.24%, reflecting a mild negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

PITTSBURGH, Oct. 29, 2024 (GLOBE NEWSWIRE) -- Lipella Pharmaceuticals, Inc. (Nasdaq: LIPO) (“Lipella” or the “Company”), a clinical-stage biotechnology company focused on addressing serious diseases with significant unmet needs, today announced that CEO Jonathan Kaufman, PhD will be presenting at the 2024 Spartan Capital Investor Conference that is being held on November 4, 2024, at the Pierre Hotel in New York.

Event: Lipella Presentation - 2024 Spartan Capital Investor Conference

Date: Monday, November 4^th, 2024

Time: 9:25 am EST

Jonathan Kaufman will be available for one-on-one meetings with registered investors of the conference.

About Lipella Pharmaceuticals
Lipella is a clinical-stage biotechnology company focused on developing new drugs by reformulating the active agents in existing generic drugs and optimizing these reformulations for new applications. Additionally, Lipella maintains a therapeutic focus on diseases with significant, unaddressed morbidity and mortality where no approved drug therapy currently exists. Lipella completed its initial public offering in December 2022. For more information, please visit www.lipella.com or LinkedIn

CONTACT

Jeff Ramson
PCG Advisory
jramson@pcgadvisory.com
646-863-6893

FAQ

When is Lipella Pharmaceuticals (LIPO) presenting at the 2024 Spartan Capital Investor Conference?

Lipella Pharmaceuticals (LIPO) will present on Monday, November 4th, 2024, at 9:25 am EST.

Where will the 2024 Spartan Capital Investor Conference featuring Lipella (LIPO) be held?

The conference will be held at the Pierre Hotel in New York.

Will Lipella Pharmaceuticals (LIPO) offer individual meetings at the Spartan Capital Conference?

Yes, CEO Jonathan Kaufman will be available for one-on-one meetings with registered investors of the conference.

What type of company is Lipella Pharmaceuticals (LIPO)?

Lipella Pharmaceuticals is a clinical-stage biotechnology company focused on addressing serious diseases with significant unmet needs.